204 related articles for article (PubMed ID: 38785269)
21. Differential Expression and Regulation of Brain-Derived Neurotrophic Factor (BDNF) mRNA Isoforms in Brain Cells from Mecp2(308/y) Mouse Model.
Rousseaud A; Delépine C; Nectoux J; Billuart P; Bienvenu T
J Mol Neurosci; 2015 Aug; 56(4):758-767. PubMed ID: 25634725
[TBL] [Abstract][Full Text] [Related]
22. 5-HT
Dai H; Kitami Y; Goto YI; Itoh M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430502
[TBL] [Abstract][Full Text] [Related]
23. Loss of MeCP2 disrupts cell autonomous and autocrine BDNF signaling in mouse glutamatergic neurons.
Sampathkumar C; Wu YJ; Vadhvani M; Trimbuch T; Eickholt B; Rosenmund C
Elife; 2016 Oct; 5():. PubMed ID: 27782879
[TBL] [Abstract][Full Text] [Related]
24. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression.
Kondo M; Gray LJ; Pelka GJ; Christodoulou J; Tam PP; Hannan AJ
Eur J Neurosci; 2008 Jun; 27(12):3342-50. PubMed ID: 18557922
[TBL] [Abstract][Full Text] [Related]
25. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
26. Neurotrophic effects of Cerebrolysin in the Mecp2(308/Y) transgenic model of Rett syndrome.
Doppler E; Rockenstein E; Ubhi K; Inglis C; Mante M; Adame A; Crews L; Hitzl M; Moessler H; Masliah E
Acta Neuropathol; 2008 Oct; 116(4):425-37. PubMed ID: 18600331
[TBL] [Abstract][Full Text] [Related]
27. Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.
Carrette LLG; Blum R; Ma W; Kelleher RJ; Lee JT
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8185-8190. PubMed ID: 30038001
[TBL] [Abstract][Full Text] [Related]
28. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome.
Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC
Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186
[TBL] [Abstract][Full Text] [Related]
29. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
Chang Q; Khare G; Dani V; Nelson S; Jaenisch R
Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Gsk3b Reduces Nfkb1 Signaling and Rescues Synaptic Activity to Improve the Rett Syndrome Phenotype in Mecp2-Knockout Mice.
Jorge-Torres OC; Szczesna K; Roa L; Casal C; Gonzalez-Somermeyer L; Soler M; Velasco CD; Martínez-San Segundo P; Petazzi P; Sáez MA; Delgado-Morales R; Fourcade S; Pujol A; Huertas D; Llobet A; Guil S; Esteller M
Cell Rep; 2018 May; 23(6):1665-1677. PubMed ID: 29742424
[TBL] [Abstract][Full Text] [Related]
31. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
[TBL] [Abstract][Full Text] [Related]
32. MeCP2 mutation results in compartment-specific reductions in dendritic branching and spine density in layer 5 motor cortical neurons of YFP-H mice.
Stuss DP; Boyd JD; Levin DB; Delaney KR
PLoS One; 2012; 7(3):e31896. PubMed ID: 22412847
[TBL] [Abstract][Full Text] [Related]
33. Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice.
Lonetti G; Angelucci A; Morando L; Boggio EM; Giustetto M; Pizzorusso T
Biol Psychiatry; 2010 Apr; 67(7):657-65. PubMed ID: 20172507
[TBL] [Abstract][Full Text] [Related]
34. Metformin Induces MeCP2 in the Hippocampus of Male Mice with Sex-Specific and Brain-Region-Dependent Molecular Impact.
Arezoumand KS; Roberts CT; Rastegar M
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672521
[TBL] [Abstract][Full Text] [Related]
35. Osteoblast function and bone histomorphometry in a murine model of Rett syndrome.
Blue ME; Boskey AL; Doty SB; Fedarko NS; Hossain MA; Shapiro JR
Bone; 2015 Jul; 76():23-30. PubMed ID: 25769649
[TBL] [Abstract][Full Text] [Related]
36. Negative Allosteric Modulation of mGluR5 Partially Corrects Pathophysiology in a Mouse Model of Rett Syndrome.
Tao J; Wu H; Coronado AA; de Laittre E; Osterweil EK; Zhang Y; Bear MF
J Neurosci; 2016 Nov; 36(47):11946-11958. PubMed ID: 27881780
[TBL] [Abstract][Full Text] [Related]
37. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation.
Belichenko NP; Belichenko PV; Mobley WC
Neurobiol Dis; 2009 Apr; 34(1):71-7. PubMed ID: 19167498
[TBL] [Abstract][Full Text] [Related]
38. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks.
Belichenko PV; Wright EE; Belichenko NP; Masliah E; Li HH; Mobley WC; Francke U
J Comp Neurol; 2009 May; 514(3):240-58. PubMed ID: 19296534
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D Supplementation Rescues Aberrant NF-κB Pathway Activation and Partially Ameliorates Rett Syndrome Phenotypes in
Ribeiro MC; Moore SM; Kishi N; Macklis JD; MacDonald JL
eNeuro; 2020; 7(3):. PubMed ID: 32393583
[TBL] [Abstract][Full Text] [Related]
40. Dendrimer nanotherapy targeting of glial dysfunction improves inflammation and neurobehavioral phenotype in adult female Mecp2-heterozygous mouse model of Rett syndrome.
Khoury ES; Patel RV; O'Ferrall C; Fowler A; Sah N; Sharma A; Gupta S; Scafidi S; Kurtz JS; Olmstead SJ; Kudchadkar SR; Kannan RM; Blue ME; Kannan S
J Neurochem; 2024 May; 168(5):841-854. PubMed ID: 37777475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
